BO
DGX icon

Bank OZK’s Quest Diagnostics DGX Stock Holding History

Bank OZK’s Portfolio DGX Stock Details DGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.25M Buy
15,322
+750
+5% +$147K 0.96% 31
2026
Q1 		$2.86M Buy
14,572
+214
+1% +$41.6K 1.01% 35
2025
Q4 		$2.49M Sell
14,358
-73
-0.5% -$13.3K 0.88% 37
2025
Q3 		$2.75M Buy
14,431
+629
+5% +$112K 0.97% 32
2025
Q2 		$2.48M Buy
13,802
+1,571
+13% +$273K 0.95% 34
2025
Q1 		$2.07M Buy
+12,231
New +$2.01M 0.86% 40

Other funds holding DGX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
EIG
EdgePoint Investment Group Toronto, Ontario, Canada $13.2B AUM 32.43% 1-Year Est. Return

Bank OZK's DGX Position: Q2 2026 in Review

Bank OZK increased its Quest Diagnostics (DGX) stake by 5.1% in Q2 2026, buying an estimated $147K and bringing the position to 15,322 shares worth $3.25M. The position accounts for 0.96% of the portfolio, ranked #31.

Bank OZK first reported a position in DGX in Q1 2025 and has held it in 6 quarters since. 1,109 funds tracked by Wall St. Rank hold DGX as of Q2 2026.

  • Bank OZK held 15,322 shares of Quest Diagnostics worth $3.25M as of Q2 2026.
  • Bank OZK bought 750 Quest Diagnostics shares in Q2 2026, an estimated $147K.
  • Quest Diagnostics made up 0.96% of Bank OZK's portfolio in Q2 2026, its #31 holding.
  • Bank OZK first reported a position in Quest Diagnostics in Q1 2025 and has held it in 6 quarters since.
  • 1,109 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2026.

Based on Bank OZK's 13F filing for Q2 2026, filed 17 Aug 2026.